Document is current
Any future updates will be listed below
-
Authors
Mitsumoto, Hiroshi https://orcid.org/0000-0001-6259-8923
Cheung, Ken
Oskarsson, Björn
Andrews, Howard F.
Jang, Grace E.
Andrews, Jinsy A.
Shah, Jaimin S.
Fernandes, Joseph Americo
McElhiney, Martin
Santella, Regina M.
-
Funding
Funding for this research was provided by:
Tsumura and Company (no number)
- License Information
-
More Information
Article History
Received: 22 December 2022
Accepted: 31 May 2023
First Online: 10 July 2023
Declarations
:
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.Hiroshi Mitsumoto, MD, DSc has received support from NIH, SPF, ALS Association, MDA Wings, Tsumura & Co., Mitsubishi-Tanabe Pharma, private donation, Wesley J. Howe Professorship and has served as a paid consultant for Eli-Lilly.Ying Kuen K. Cheung, PhD, has received support from Tsumura & Co. for the current study.Björn Oskarsson, MD, has received support from Tsumura & Co, serves as a consultant for MediciNova Inc., and Mitsubishi and have research funding from NINDS, Biogen, MediciNova, Cytokinetics, Mitsubishi, Calico, Sanofi, and TARGET ALS.Grace E. Jang, BA, has received support from Tsumura & Co.Howard Andrews, MS, PhD, directs the core facility that receives support from Tsumura & Co for data management; Dr. Andrews serves as the unblinded biostatistician.Jinsy A, Andrews MD, MS, has received research funding to her institution from Amylyx, Biogen, Cytokinetics, Novartis, MGH Foundation/Ra Pharma, Biohaven/Clene/Prilenia (Platform Trial) and has served as a consultant for AL-S Pharma, Amylyx, Apellis, Biogen, Cytokinetics, Denali, Orphazyme, Quralis Neurosense, Novartis, Sanofi, UCB, and Wave Life Sciences.Jaimin S. Shah, MD has received research funding from the Muscular Dystrophy Association, Corbus Pharmaceuticals, Argenx, MGH Foundation, Clene, and Prilenia.Joseph Americo Fernandes, Jr, MD, has received support from Tsumura & Co, MGH foundation, Ra Pharma, Biohaven, Clene, Seelos Therapeutics, Prilenia, and Columbia University.Martin McElhiney, PhD, has no conflicts of interest.Regina M. Santella, PhD, directs the core facility that receives support from Tsumura & Co for processing blood samples.
